PBCAR19B
PBCAR19B-01
Phase 1 gene_therapy completed
Quick answer
PBCAR19B for CD19 Expressing Malignancies is a Phase 1 program (gene_therapy) at PRECISION BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PRECISION BIOSCIENCES INC
- Indication
- CD19 Expressing Malignancies
- Phase
- Phase 1
- Modality
- gene_therapy
- Status
- completed